Translational Development Acquisition Corp.
NASDAQ:TDACShell Companies
-$0.01 today
- Market cap
- $267.99M
- Beta
- 0.01
- P/E (TTM)
- 29.8
- EPS (TTM)
- $0.36
Volume 0.47M
Average 0.10M
TDAC Other Current Liabilities
Short-term obligations not reported separately, such as accrued expenses.
Translational Development Acquisition Corp.NASDAQ: TDAC
Other Current Liabilities · Q1 FY2026 · quarter ended Mar 2026
Other current liabilities turns positive
Q1 FY2026 other current liabilities was $361.09K, compared with -$6.21M a year earlier.
Context
- Other current liabilities amounted to 0.2% of total assets at the end of Q1 FY2026, down 3.3 pp from a year earlier.
- Other current liabilities increased in 1 of the last 3 fiscal years.
What to watch
Whether other current liabilities keeps rising in the next quarterly balance sheet after a +105.8% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 0 USD
- Year-over-year change
- +100.0%
| Period | Period end | Other Current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | +100.0% |
| FY2024 | 2024-12-31 | (6.11T) | -488081229931.9% |
| FY2023 | 2023-12-31 | (1.25K) | -100.6% |
| FY2022 | 2022-12-31 | 200.34K | — |
Other Current Liabilities vs competitors
How TDAC compares with its peers on the latest reported figures
- TDAC's Mar 2026 other current liabilities of $361.09K is the 3rd highest of the 7 companies compared; the peer median is $175.58K.
- Its year-over-year change of +105.8% is the 2nd highest of 4, against a peer median of +9.2%.
- Other current liabilities amounts to 0.2% of total assets for TDAC, versus a peer median of 0.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $380.03K | +272.8% | -55.7% | 0.2% | |
| Mar 2026 | $364.74K | — | — | 0.2% | |
| Mar 2026 | $361.09K | +105.8% | — | 0.2% | |
| Jun 2025 | $212.43K | — | — | 50.9% | |
| Mar 2026 | $138.74K | +9.2% | -83.1% | 0.1% | |
NTWONewbury Street II Acquisition Corp | Mar 2026 | $127.12K | — | — | 0.1% |
MACIMelar Acquisition Corp. I | Mar 2026 | $0 | -100.0% | — | 0.0% |
| Peer median (excluding TDAC) | $175.58K | +9.2% | -69.4% | 0.1% | |
Competitors are the stored peer set for TDAC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Translational Development Acquisition Corp.
NASDAQ:TDAC
Intrinsic Alpha fair value
Locked
Current Price
$10.88
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.